Warning
Mae'r hysbyseb swydd hon wedi dod i ben ac mae'r ceisiadau wedi cau.
Consultant Orthopaedic Oncology Surgeon | The Newcastle upon Tyne Hospitals NHS Foundation Trust
| Dyddiad hysbysebu: | 20 Medi 2024 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £105,504 - £139,882 per annum |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 20 Hydref 2024 |
| Lleoliad: | Newcastle upon Tyne, NE1 4LP |
| Cwmni: | The Newcastle upon Tyne Hospitals NHS Foundation Trust |
| Math o swydd: | Parhaol |
| Cyfeirnod swydd: | 6661423/317-CON-24-212 |
Crynodeb
We are delighted to be able to offer an opportunity for a highly motivated, ambitious individual to join our wellintegrated Multi-Disciplinary Sarcoma Team. Thesuccessfulcandidatewillbecome an integral member ofasurgicalteamofthreeOrthopaedic Surgeons and three Plastic Surgeons treating Soft-Tissue and Bony Sarcomas. The successful candidate will join as a co-chair of the Sarcoma MDT, and have primary responsibility for bony sarcomas in both adult and paediatric patients. Additional roles include the treatment of complex and tertiary referral metastatic bone disease and the opportunity to engage in elective arthroplasty. The candidate must have fellowship training in Orthopaedic Oncology.
In addition to the challenges of the role, we can offer you a commitment to teaching, education, research and audit. Candidates for the post must be registered medical practitioners and on, or eligible to join, the Specialist Register within six months of the date of the Appointments Committee.
· ThesuccessfulcandidatewilljointheexistingSarcoma Service ‘Surgeon of the week’rotawith responsibility for referral triage and chairing the weekly MDT meeting.
· The successful candidate will be encouraged to develop their special interest and will be supported with peer mentoring, a close-knit and high functioning MDT, and dual consultant operating.
· The successful candidate will be required to treat benign and malignant bony and soft-tissue tumours in both adult patients at the Freeman Hospital, and paediatric patients at the Great North Children’s Hospital on the RVI site.
· The successful candidate will help to further develop the tertiary referral metastatic bone disease service in line with national BOAST guidelines.
· Play an active role in reviewing cancer targets and service specification.
· Participateinaudit andclinicalgovernance.
· Showacommitmenttocontinuingprofessionaldevelopment.
· Participateinannualappraisal(forrevalidation)andintheannualjob planningprocess.
· Work with and support all members of the clinical team.
For an informal discussion and further information regarding the opportunity and Directorate, please contact: Mr Paul Sandersonon 0191 282 5083 (secretary) or via email at paul.sanderson@nhs.net
Closing Date: Sunday 29 September 2024
Interview Date: Monday 4November 2024
Thesuccessfulcandidatewillbecome an integral member ofasurgicalteamofthreeOrthopaedic Surgeons and three Plastic Surgeons treating Soft-Tissue and Bony Sarcomas. The successful candidate will join as a co-chair of the Sarcoma MDT, and have primary responsibility for bony sarcomas in both adult and paediatric patients, with the additional role of treating complex and tertiary referral metastatic bone disease.
This advert closes on Sunday 29 Sep 2024
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.